Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06801678 · ClinicalTrials.gov registry record
Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations
A clinical trial of Cataract, sponsored by The Eye institute of Utah.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06801678 is a study of Cataract that is actively recruiting participants, run by The Eye institute of Utah. The registered enrollment target is 50 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06801678, a study of Cataract, is actively recruiting participants, sponsored by The Eye institute of Utah.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.
Conditions Studied
Study Locations (1)
Utah
- The Eye Institute of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-01-09 |
| Est. Completion | 2025-02-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06801678
The ClinicalTrials.gov registry entry for NCT06801678 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (78% lower). The listed sponsor is The Eye institute of Utah, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 0 interventions.
NCT06801678 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06801678 about?
NCT06801678 is a clinical study titled "Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations". The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoin...
What is the current status of trial NCT06801678?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-01-09. Estimated completion is 2025-02-22.
What conditions does trial NCT06801678 study?
This clinical trial studies the following conditions: Cataract.
Who is sponsoring clinical trial NCT06801678?
This trial is sponsored by The Eye institute of Utah, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06801678 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.